What is CheckEye?
AI-driven platform for mass screening of chronic diseases to enable preventive healthcare for everyone around the world
Problem
According to the World Health Organization, chronic diseases such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes are the leading causes of death globally, responsible for over 70% of all deaths. This equates to 41 million people each year, with 15 million of these deaths occurring prematurely, between the ages of 30 and 69.
‘Chronic diseases are a global challenge, but through prevention, early detection, and timely treatment, millions of lives can be saved’
– WHO
The World Health Organisation defines diabetic retinopathy as the leading cause of blindness in the working age population in most countries. However, early diagnosis and timely treatment of diabetic retinopathy can prevent sight impairment and blindness. Interventions that are both cost-saving and feasible include screening and treatment for retinopathy.
approximately 2% of people become blind,
and about 10% develop severe visual impairment.’
– World Health Organisation
Solution
CheckEye has developed a cloud-based solution to detect a wide range of chronic diseases, including diabetic retinopathy, using photographic images of the eye fundus through advanced ML/AI algorithms. These photographs can be taken anywhere, from optical retailers to pharmacies, by non-medical staff and then uploaded to the system for diagnosis. CheckEye makes early detection and prevention of chronic diseases, including diabetic retinopathy, accessible to everyone
Who benefits?
The public health and economic benefits of early detection, prevention, and treatment of chronic diseases, including diabetic retinopathy, are immense
PATIENTS
REDUCED WAITING TIME
Reduced waiting time to access professional treatment by receiving quick and accurate retinopathy screening test results in a wide network of locations.
BETTER COST EFFICIENCY
More cost-effective treatment of chronic diseases
TIMELY TREATMENT
Early detection and timely treatment of chronic diseases improve health outcomes and reduce costs
BETTER VISION FOR LIFE
Mitigate the risk of developing severe cases of chronic diseases, including retinopathy and blindness
EYE HEALTH PROFESSIONALS
MORE QUALITY TIME WITH PATIENTS
Mobile screening for chronic diseases increases the efficiency of specialists by freeing up time spent on routine screenings, allowing them to focus on more complex cases
ACCURATE DIAGNOSIS
More accurate diagnosis through better quality of screening images achieved with AI-based technology
BETTER PERFORMANCE RESULTS
Higher rate of appointments for patients with screen-positive results who require treatment more urgently.
PUBLIC HEALTH SYSTEMS & INSURANCE COMPANIES
BETTER ACCESS TO SCREENING
Lowering the barriers to access and reducing the cost of systematic chronic disease screening tests help to decrease the disease burden on public health and social care systems
LESS FINANCIAL BURDEN
Early detection of chronic diseases significantly reduces treatment costs by preventing complications and the need for more intensive care
MORE ACCURATE SCREENING RESULTS
Automated image analysis systems provide a more accurate diagnosis compared to the manual grading, thus allowing to prioritise patients for treatment based on the severity of their condition.
LESS ADMIN WORK FOR MEDICAL PERSONNEL
Where there are staff shortages and/or limited access to treatments, the system prioritises patients automatically based on the severity of their condition.
Our team
CheckEye operates an international team based in the UK, Ukraine and Switzerland. Our shared credentials include decades of senior level experience across IT, telecom and health industries in global brands, higher education in the world’s best universities, and a profound understanding of the rapidly evolving healthcare trends globally.
Kirill Goncharuk,
CEO
Kirill is a senior IT professional with two decades of technology and IT product development experience. His role at CheckEye encompasses both general management and product development, underpinned by expertise gained across Kirill’s work in large corporates in information technology & security and business continuity roles across industries – energy, system integration and telecom. Kirill has been on the senior leadership teams in Ukraine’s largest names such as VEON, DTEK, and currently Ukrtelecom.
Kirill is a candidate for Global Executive MBA from IESE Business School, University of Navarra.
Dmitry Sofyna,
CTO
Dmitry is the head of the Artificial Intelligence Research and Development Center. He has over 10 years of experience in analyzing business needs and developing digital solutions. Prior to this, he worked in the field of finance and banking. He holds two higher education degrees. He is the founder and Chairman of the Supervisory Board of the Vinnytsia IT Association. He is also the founder of the UME ecosystem for learning and work. He is the author of the Country’s Digital Transformation concept.
Andrii Korol,
Medical Advisor
Andrii is a Doctor of Medical Sciences, Senior Researcher, Head of the Department of Studying the Biological Action and Application of Lasers in Ophthalmology of the “The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine”, specialisation in ophthalmology: diagnosis of fundus diseases, laser microsurgery, treatment of fundus diseases using antiangiogenic factors. Author of 39 scientific articles in international journals included in the Scopus scientometric database, two monographs, scientific supervisor of three dissertations.
Member of the Ukrainian Society of Ophthalmologists, European Society of Retina Specialists – EURETINA, International Expert Group of Vision Academy.
Michael Shuranov, Communications Advisor
Michael is a senior communications professional bringing over 20 years of hands-on experience in public relations and reputation management. Having worked in senior communications roles in large corporates across food, retail and telecom including McDonald’s, Avon, VEON and currently Ukrtelecom, the largest telco in Ukraine, Michael advises CheckEye on the high level strategic positioning and comm steam design.
Michael teaches Media Relations at the Chartered Institute of Public Relations, Ukraine.
Daria Partas,
Head of Communications
Daria is a London-based strategic communications advisor and reputation management expert with over 15 years of experience. Daria’s career includes working in communication roles in/with complex matrix cross-border organisations such as BT, VEON, United Nations, and CNN International. With over 15 years of experience in international communications, she is responsible for developing the brand vision, core positioning and global communications strategies for CheckEye.
Daria graduated with an MA in Digital Culture and Society from King’s College London. She holds a CIPR Professional PR Diploma from London’s PR Academy and a Certificate in Analyst Relations from Forrester.
News
The Ukrainian HealthTech startup CheckEye won the EIT Health InnoStars Awards 2024, becoming the first company from Ukraine to receive pan-European recognition in this competition
On November 27, 2024, a Ukrainian team made history by winning the prestigious EIT Health InnoStars Awards, thanks to the innovative HealthTech startup CheckEye. This victory marks a transformative milestone for the Ukrainian medical technology sector, showcasing the...
CheckEye secures investment from Austria’s largest and most renowned pharmacy
Austria has become a strategic partner of the Ukrainian platform CheckEye, specializing in early diagnosis of chronic diseases using artificial intelligence. Investments from the country’s largest pharmacy, Marien-Apotheke, open new opportunities for advancing...
CheckEye joins the EBRD Star Venture Programme
We are proud to announce that CheckEye has been selected as one of the 10 high-potential startups to join the prestigious EBRD Star Venture Programme. This 18-month program, funded by the Swiss Agency for Development and Cooperation, is designed to support innovative...
CheckEye: The first AI-based platform in Europe implementing a national chronic disease screening and complications program amid martial law
November 14, 2024, – On the occasion of World Diabetes Day, the CheckEye platform presents the results of its initiatives in the diagnosis of diabetic retinopathy (DR) at the national level. CheckEye is the first AI-based platform in Europe to conduct nationwide DR...
CheckEye at FUTURE FORCES FORUM 2024
The CheckEye team participated in FUTURE FORCES FORUM 2024 in Prague — one of the most influential international events dedicated to defense, security, and cutting-edge technologies. The forum was split into two parts: NATO defense strategies and civil security, where...
CheckEye has been chosen as a semi-finalist for the EIT Health Catapult 2024-25
This recognition is a testament to our relentless dedication to transforming healthcare through cutting-edge digital eye screening. From the very beginning, our mission has been clear: harness the power of technology to detect chronic diseases early and make...
Launching a pilot project in Chernihiv Region!
The CheckEye team, in collaboration with HELSI has launched a pilot project in the Borzna, Chernihiv region, at CNE "Borznyanskyi CPMSA."🎯The project’s main goal is to screen for diabetic retinopathy, a common and serious complication of diabetes that can lead to...
CheckEye at Pitch to the Beat
On October 19th, the CheckEye team participated in the unforgettable Pitch to the Beat event in Kyiv. This was a fantastic opportunity for us to present our innovative solutions for screening chronic diseases and their complications, particularly through fundus...
CheckEye is one of the selected start-ups for the prestigious HICEE Start-up Support Programme by EIT Health InnoStars!
This programme focuses on empowering innovative ventures in life sciences, including biotech, medtech, and digital health. As one of the chosen participants, we’re gearing up for a journey filled with tailored support and guidance.What does this mean for CheckEye?💡...
Innovations in Medical Technology: Ukraine’s Experience at DOG 2024
Last week in Berlin, our Medical R&D Director, Andrii Korol, presented at the DOG 2024, where leaders in the field gathered to discuss advancements in medical technology. Andrii showcased the Ukrainian experience of leveraging AI technology for mass screening of...
Partners
